Secret Heart Funding Talks Behind Closed Doors
Published Date: 9/17/2025
Notice
Summary
The National Heart, Lung, and Blood Institute is holding a private meeting on October 29, 2025, to review grant applications that could include sensitive information. This meeting affects researchers seeking funding and helps decide which projects get support. If you want to share your thoughts, you can send written comments before the meeting.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed grant-review meeting on Oct 29
If you are a researcher applying for NHLBI grants, your applications will be reviewed at a closed National Heart, Lung, and Blood Advisory Council meeting on October 29, 2025, from 8:00 a.m. to 8:30 a.m. in Bethesda, MD. The meeting will review and evaluate grant applications and could affect which projects receive NIH support; discussions may include confidential trade secrets and personal information.
Public can submit written comments
Any interested person may file written comments with the committee before the meeting by sending a statement (including name, address, telephone number, and, if applicable, business or professional affiliation) to the Contact Person listed in the notice (Charisee Lamar). Comments should be submitted prior to the October 29, 2025 meeting.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
Previous / Next Documents
Previous: 2025-17998, National Heart, Lung, and Blood Institute; Notice of Meeting
The National Heart, Lung, and Blood Institute is holding a public meeting on October 29, 2025, to talk about important program policies and issues. Anyone interested can attend in person or watch online, and people can also send in written comments or request to speak. This is a great chance for the public and organizations to share their thoughts and stay involved with health research decisions.
Next: 2025-18000, Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help drug makers create better treatments for adults with symptomatic nonerosive gastroesophageal reflux disease (sGERD), a type of acid reflux without visible damage. This guide explains how to design clinical trials that prove new drugs work and are safe. Drug developers should check it out soon to speed up their research and bring relief to patients faster.